Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice ; volume:9 ; number:1 ; day:27 ; month:7 ; year:2021 ; pages:1-24 ; date:12.2021
Acta Neuropathologica Communications ; 9, Heft 1 (27.7.2021), 1-24, 12.2021

Creator: Jeong, Angela
Cheng, Shaowu
Zhong, Rui
Bennett, David A.
Bergö, Martin O.
Li, Ling

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-021-01231-5

URN: urn:nbn:de:101:1-2021102419501667072161

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jeong, Angela
Cheng, Shaowu
Zhong, Rui
Bennett, David A.
Bergö, Martin O.
Li, Ling
SpringerLink (Online service)

Other Objects (12)

Plaque complement activation and cognitive loss in Alzheimer's disease

Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease

Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease

Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

Advances in Drug Therapy for Alzheimer’s Disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Plaque complement activation and cognitive loss in Alzheimer's disease

Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease

Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease

Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

Advances in Drug Therapy for Alzheimer’s Disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Plaque complement activation and cognitive loss in Alzheimer's disease

Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease

Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease

Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

Advances in Drug Therapy for Alzheimer’s Disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Plaque complement activation and cognitive loss in Alzheimer's disease

Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease

Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease

Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

Advances in Drug Therapy for Alzheimer’s Disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Plaque complement activation and cognitive loss in Alzheimer's disease

Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease

Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease

Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

Advances in Drug Therapy for Alzheimer’s Disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Plaque complement activation and cognitive loss in Alzheimer's disease

Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease

Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease

Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

Advances in Drug Therapy for Alzheimer’s Disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Related objects

Reset password